Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11316649rdf:typepubmed:Citationlld:pubmed
pubmed-article:11316649lifeskim:mentionsumls-concept:C0273115lld:lifeskim
pubmed-article:11316649lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:11316649lifeskim:mentionsumls-concept:C0038891lld:lifeskim
pubmed-article:11316649lifeskim:mentionsumls-concept:C0205228lld:lifeskim
pubmed-article:11316649pubmed:issue5lld:pubmed
pubmed-article:11316649pubmed:dateCreated2001-4-24lld:pubmed
pubmed-article:11316649pubmed:abstractTextThe efficacy of exogenous surfactant administration is influenced by numerous factors, which has resulted in variable outcomes of clinical trials evaluating this treatment for the acute respiratory distress syndrome (ARDS). We investigated several of these factors in an animal model of acid aspiration including different surfactant preparations, and different delivery methods. In addition, high-frequency oscillation (HFO), a mode of mechanical ventilation known to recruit severely damaged lungs, was utilized. Lung injury was induced in adult rabbits via intratracheal instillation of 0.2 N HCl followed by conventional mechanical ventilation (CMV) until Pa(O2)/FI(O2) values ranged from 220 to 270 mm Hg. Subsequently, animals were given one of three surfactants administered via three different methods and physiological responses were assessed over a 1-h period. Regardless of the surfactant treatment strategy utilized, oxygenation responses were not sustained. In contrast, HFO resulted in a superior response compared with all surfactant treatment strategies involving CMV. The deterioration in physiological parameters after surfactant treatment was likely due to overwhelming protein inhibition of the surfactant. In conclusion, various surfactant treatment strategies were not effective in this model of lung injury, although the lungs of these animals were recruitable with HFO, as reflected by the acute and sustained oxygenation improvements.lld:pubmed
pubmed-article:11316649pubmed:languageenglld:pubmed
pubmed-article:11316649pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316649pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11316649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316649pubmed:statusMEDLINElld:pubmed
pubmed-article:11316649pubmed:monthAprlld:pubmed
pubmed-article:11316649pubmed:issn1073-449Xlld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:LewisJ FJFlld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:LaiY LYLlld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:VeldhuizenR...lld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:NikoreVVlld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:PuligandlaP...lld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:McCaigL ALAlld:pubmed
pubmed-article:11316649pubmed:authorpubmed-author:BrackenburyA...lld:pubmed
pubmed-article:11316649pubmed:issnTypePrintlld:pubmed
pubmed-article:11316649pubmed:volume163lld:pubmed
pubmed-article:11316649pubmed:ownerNLMlld:pubmed
pubmed-article:11316649pubmed:authorsCompleteYlld:pubmed
pubmed-article:11316649pubmed:pagination1135-42lld:pubmed
pubmed-article:11316649pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:meshHeadingpubmed-meshheading:11316649...lld:pubmed
pubmed-article:11316649pubmed:year2001lld:pubmed
pubmed-article:11316649pubmed:articleTitleEvaluation of exogenous surfactant in HCL-induced lung injury.lld:pubmed
pubmed-article:11316649pubmed:affiliationDepartments of Physiology and Medicine, Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada. abeye@julian.uwo.calld:pubmed
pubmed-article:11316649pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11316649pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11316649pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed